Archives of Clinical and Biomedical Research



Abstracting and Indexing



The Use of Allogeneic Leukocytes Infusion in Cancer Immunotherapy

Mixed allogeneic lymphocyte response has activated considering T lymphocytes and elicit type 1 cytokines which induced antitumor immunity. Using TC-1 cancer model, we demonstrated the response of inactivated allogeneic leukocytes infusion (ALI) to generate antitumor immune response. In TC-1 tumor model, ALI induced a delayed cancer development and a prolonged survival. Our study illustrated that ALI might elicit strong antitumor immune response. The method strategy would be easy and efficient strategy in tumor immunotherapy.


Yishu Tang, Chunxia Zhou, Wenbo Ma, Dongmei Wang, Shuren Zhang

Abstract PDF Full Text View at
News & Announcements

Fortune Journals follows COPE Guidelines